EVTV stock jumps again as Envirotech Vehicles rides AZIO AI’s $107 million GPU order headline
13 January 2026
1 min read

EVTV stock jumps again as Envirotech Vehicles rides AZIO AI’s $107 million GPU order headline

NEW YORK, Jan 13, 2026, 13:06 EST — Regular session

  • Shares of Envirotech Vehicles climbed roughly 84% by midday, following Monday’s massive 442% surge.
  • Proposed merger partner AZIO AI pointed to a binding government GPU order valued at roughly $107 million.
  • Deal paperwork is expected soon, with a shareholder meeting set for Jan. 20.

Envirotech Vehicles, Inc (EVTV.O) saw its shares surge roughly 84% to $4.61 on Tuesday, pushing a two-day rally that has made the small U.S.-listed stock a momentum play. During the session, shares fluctuated from $2.62 up to $4.75. 1

The significance lies in EVTV’s modest market cap—around $22 million—being linked to a far bigger revenue number. That discrepancy alone can draw quick capital, despite sparse details and delayed timelines.

AZIO AI, the company Envirotech Vehicles is looking to acquire, announced Monday it secured a binding purchase order for 256 Nvidia B300 GPUs — chips designed for demanding AI workloads — linked to a Southeast Asian government project. The deal is valued at roughly $107 million in “contractual revenue,” with AZIO AI expecting a 30% deposit “over the course of the next few weeks.” “Delivering approximately $100 million in contractual revenue … demonstrates our ability to deploy … AI infrastructure at scale,” said Chris Young, AZIO AI’s co-CEO, in the statement. 2

Last week, Envirotech Vehicles announced it had signed an amended and restated letter of intent — a non-binding outline — to acquire 100% of AZIO AI via a statutory merger. The deal framework valued AZIO AI at $480 million and pegged a reference price of $3.00 per EVTV share. However, the company cautioned there’s no guarantee a definitive agreement will be reached or the transaction completed. 3

EVTV’s stock exploded 442% on Monday, finishing at $2.51. Over 750 million shares traded hands, per StockAnalysis data. 4

Envirotech Vehicles has pushed its annual shareholder meeting to Jan. 20, according to an SEC filing, after failing to reach a quorum. 5

What’s tough to gauge is how fast this will translate into EVTV’s financial results. The purchase orders and pipeline figures belong to AZIO AI, not Envirotech’s traditional operations, and the merger is still just a framework.

There are clear risks in the opposite direction. The LOI doesn’t bind either party to complete the deal, and the “pipeline” AZIO AI pointed out still needs contract finalization and signing. The deposit terms are conditional too, and EVTV’s stock has already proven it can swing sharply both ways on this story.

Traders are waiting on filings to clarify the deal — a signed merger agreement, details on consideration and governance, plus any regulatory or shareholder approvals required to issue stock. Expect an 8-K or proxy update to surface first.

Envirotech Vehicles is set to reconvene its annual meeting on Jan. 20. After that, focus turns to whether AZIO AI will report the anticipated deposit in the “next few weeks” and if the merger framework will materialize into a definitive agreement.

Stock Market Today

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

7 February 2026
Applied Digital Corporation shares jumped 25.52% Friday to $34.95, then slipped to $34.60 after hours. The company reported fiscal Q2 revenue up 250% to $126.6 million and signed leases for 600 MW of data center capacity in North Dakota. Applied Digital broke ground on a new 430‑MW campus in the southern U.S. in January. Financing includes a $100 million promissory note with 8% interest, paid in kind.
Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

7 February 2026
Eli Lilly shares rose 3.7% to $1,058.18 Friday after the FDA said it would act against telehealth firm Hims & Hers for marketing a $49 compounded weight-loss pill. The move followed a sharp selloff Thursday when Hims announced plans to sell a version of Novo Nordisk’s Wegovy. Investors remain uncertain how aggressively regulators will police copycat drugs and pricing in the obesity drug market.
Applied Digital stock slides after insider sale filing — what investors watch next
Previous Story

Applied Digital stock slides after insider sale filing — what investors watch next

Arcus Biosciences stock jumps on Goldman upgrade as traders eye JPM Healthcare stage
Next Story

Arcus Biosciences stock jumps on Goldman upgrade as traders eye JPM Healthcare stage

Go toTop